Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
docetaxel (taxotere) (1 trial)
immuvac (1 trial)
Mycobacterium Infections (Phase 2)
Prostatic Neoplasms (Phase 2)
Trials (1 total)
Trial APIs (2 total)